Clinical trial · Observational
Comparison of Combined (Superficial and Deep) and Isolated Deep Serratus Anterior Plane Blocks After Breast Surgery
Investigation of the Effectiveness of Ultrasonography-Guided Deep Serratus Anterior Plane Block and Combined Superficial and Deep Serratus Anterior Plane Block on Postoperative Pain in Patients Undergoing Modified Radical Mastectomy and Breast-Conserving Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose of this study is to compare the effectiveness of two different regional anesthesia techniques for pain management after oncological breast surgeries. The researchers will compare the combined (superficial and deep) serratus anterior plane block with the deep serratus anterior plane block. The study aims to evaluate which method provides better postoperative pain relief, reduces the total consumption of opioid analgesics, and improves patient comfort
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Pain Management After Surgery | — | UNRESOLVED | — |
| Postoperative Pain | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Combined Serratus Anterior Plane Block Group
- description
- Patients receiving both superficial and deep serratus anterior plane block
- label
- Isolated Deep Serratus Anterior Plane Block Group
- description
- Patients receiving only deep serratus anterior plane block
Primary outcomes (1)
- measure
- Visual Analog Scale (VAS) Scores for Postoperative Pain
- timeFrame
- Postoperative 24 hours.
- description
- Assessment of postoperative pain using the Visual Analog Scale (VAS) (minimum score: 0, maximum score: 10, where higher scores indicate worse outcome).
Secondary outcomes (6)
- measure
- Total Tramadol Consumption
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: Patients aged 18-80 years. Female patients with ASA physical status I, II, or III. Patients scheduled for elective modified radical mastectomy or breast-conserving surgery. Patients who provided written and verbal informed consent. Exclusion Criteria: Patients with ASA physical status IV-V. Patients with a BMI ≥ 35 kg/m². Patients with chronic pain, opioid/substance addiction, or long-term analgesic use. Patients requiring emergency surgery. Pregnant patients. Known allergy to local anesthetics. Severe cardiovascular, cerebrovascular, liver, or renal disease. History of coagulopathy. Infection at the injection site or systemic infection. Patients who refuse the regional anesthesia technique, cannot speak the official language, or have mental disabilities/inability to cooperate. Patients with a history of previous breast surgery or those scheduled for bilateral operations.
References
Publications (0)
Data not yet available